EAN
UTHR icon

Excelsior Advisor Network’s United Therapeutics UTHR Stock Holding History

Excelsior Advisor Network’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$530K Hold
979
– – 0.07% 257
2026
Q1 		$581K Buy
+979
New +$488K 0.22% 92

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Excelsior Advisor Network's UTHR Position: Q2 2026 in Review

Excelsior Advisor Network held its United Therapeutics (UTHR) position steady in Q2 2026 at 979 shares worth $530K. The position accounts for 0.07% of the portfolio, ranked #257.

Excelsior Advisor Network first reported a position in UTHR in Q1 2026 and has held it in 2 quarters since. The position peaked at $581K in Q1 2026. 877 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Excelsior Advisor Network held 979 shares of United Therapeutics worth $530K as of Q2 2026.
  • Excelsior Advisor Network left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.07% of Excelsior Advisor Network's portfolio in Q2 2026, its #257 holding.
  • Excelsior Advisor Network first reported a position in United Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Excelsior Advisor Network's United Therapeutics position peaked at $581K in Q1 2026.
  • 877 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Excelsior Advisor Network's 13F filing for Q2 2026, filed 14 Aug 2026.